Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease

Respirology

Volumn 20, Issue 4, 2015, Pages 667-670

  Eltboli, Osama ^a,b   Mistry, Vijay ^a   Barker, Bethan ^a   Brightling, Chris E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

Author keywords

blood eosinophil; chronic obstructive pulmonary disease; remodelling; reticular basement membrane; submucosal eosinophil

Indexed keywords

CORTICOSTEROID; BIOLOGICAL MARKER;

ARTICLE; BASEMENT MEMBRANE; BLOOD; BRONCHUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EOSINOPHIL COUNT; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; MAST CELL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; ADULT; EOSINOPHIL; FEMALE; LEUKOCYTE COUNT; MALE; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; BASEMENT MEMBRANE; BIOMARKERS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84927910638     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12475     Document Type: Article

References (7)

1. Eltboli O, Brightling CE,. Eosinophils as diagnostic tools in chronic lung disease. Expert Rev Respir Med 2013; 7: 33-42.
2. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID,. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356: 1480-1485.
3. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J,. Corticosteroid reversibility in COPD is related to features of asthma. Am J RespirCrit Care Med 1997; 155: 1529-1534.
4. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, et al. Acute Exacerbations of COPD: identification of biological clusters and their biomarkers. Am J RespirCrit Care Med 2011; 184: 662-671.
5. Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 48-55.
6. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P,. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380: 651-659.
7. Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R,. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med 2014; 2: 891-901.